Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis.

Kendra J GrubbJohn C LiskoDaniel O'HairWilliam MerhiJohn K ForrestPaul MahoneyNicolas M Van MieghemStephan WindeckerSteven J YakubovMathew R WilliamsStanley J ChetcutiG Michael DeebNeal S KleimanAndrew D AlthouseMichael J Reardon

Published in: JACC. Cardiovascular interventions (2024)

A low incidence of reintervention was observed for CoreValve/Evolut R/PRO and SAVR through 5 years. Reintervention occurred most often at ≤1 year for TAVR and >1 year for SAVR. Most early reinterventions were with the first-generation CoreValve and managed percutaneously. Reinterventions were more common following CoreValve TAVR compared with Evolut TAVR or SAVR.

Keyphrases

transcatheter aortic valve implantation
aortic stenosis
aortic valve replacement
transcatheter aortic valve replacement
aortic valve
ejection fraction
left ventricular
coronary artery disease
risk factors
early onset
drug induced